Category: Patients/Healthcare Providers

Update to Chronic Obstructive Pulmonary Disease (COPD) – Stable

All TreatGx users now have access to the updated treatment algorithm for Chronic Obstructive Pulmonary Disease (COPD) – Stable. As always, this update includes the TreatGx standard of providing personalized dosing based on any applicable pharmacogenetics, kidney function, liver function, and…

Read More

Update to Migraine Prophylaxis

All TreatGx users now have access to the updated treatment algorithm for Migraine Prophylaxis. This update accounts for revisions made to existing clinical guidelines and will help health care providers select the safest and most effective medications with their patients. The…

Read More

Update to Chronic Heart Failure

All TreatGx users now have access to the updated treatment algorithm for Chronic Heart Failure. As always, these updates include the TreatGx standard of providing personalized dosing based on pharmacogenetics, kidney function, liver function, and drug interactions. This update includes recommendations…

Read More

General Update (CYP2C19)

General Update GenXys is one of the first groups to update our comprehensive precision prescribing algorithm to include the latest release from the Clinical Pharmacogenetics Implementation Consortium (CPIC) CYP2C19 Genotype and Clopidogrel Therapy, published January 19, 2022. We stay at the…

Read More

Update to ADHD

All TreatGx users now have access to the updated treatment algorithm for ADHD. ADHD This update accounts for revisions made to existing clinical guidelines and will help health care providers select the safest and most effective medications with their patients. This…

Read More

Updates to Post-Myocardial Infarction and Osteoporosis

All TreatGx users now have access to the updated treatment algorithms for Post-Myocardial Infarction and Osteoporosis. As always, these updates include the TreatGx standard of providing personalized dosing based on pharmacogenetics, kidney function, liver function, and drug interactions.  Post-Myocardial Infarction This update includes recommendations from…

Read More

Update to Diabetes Mellitus Type 2

All TreatGx users now have access to the updated treatment algorithm for Diabetes Mellitus Type 2. Diabetes Mellitus Type 2  This comprehensive update accounts for revisions made to existing clinical guidelines that will help health care providers select the safest and most effective medications with their…

Read More

Updates to Hypertension, Migraine, and pharmacogenetics

All TreatGx users now have access to the updated treatment algorithms for Hypertension and Migraine. As always, these updates include the TreatGx standard of providing personalized dosing based on pharmacogenetics, kidney function, liver function, and drug interactions. General updates: a scope…

Read More

Exciting Release – Introducing GenXys Enterprise Solutions 2.4

We’ve got an exciting product release to share with you. This enterprise release of our software extends the capability, interoperability, security, and performance of the most robust and most performant pharmacogenetic (PGx) supported precision prescribing platform on the market. Falling into…

Read More

Update – Schizophrenia

We are pleased to announce an update to our Schizophrenia treatment algorithm. All TreatGx users now have access to the updated algorithm which includes many exciting enhancements that will help health care providers select the safest and most effective medications for…

Read More